Scientists Map Key Step in Enterovirus Replication, Opening Path for New Antiviral Drugs
Similar Articles
New Imaging Technique Reveals Immune Cell Killing Machinery
Scientists Discover Freshwater Protist With Rewritten Genetic Code
New Microscopy Technique Maps Cellular Sugar Coats, Revealing Health and Disease States
Scientists Develop Plastic Film That Physically Destroys Viruses on Contact
Researchers Identify New Enzyme Target That Reduces Alzheimer's Plaques in Lab Studies
Researchers have visualized for the first time how a critical viral protein complex binds to RNA to control the replication of enteroviruses, which cause illnesses from the common cold to polio. The discovery reveals a shared mechanism across multiple viruses and identifies a precise target for new antiviral drugs currently in development. This foundational work could lead to treatments for a wide range of viral infections.
Facts First
- UMBC researchers visualized the structure of the enterovirus 3CD protein complex bound to viral RNA.
- The 3CD complex acts as a molecular switch controlling whether the virus copies its genome or makes proteins.
- The mechanism appears similar across seven studied enteroviruses, including those causing polio and myocarditis.
- The finding contradicts earlier models, showing two separate 3CD molecules bind side-by-side on the RNA.
- Drugs targeting the 3C and 3D proteins are already under development.
What Happened
Researchers at the University of Maryland, Baltimore County (UMBC) have captured the first detailed structure of a key enterovirus protein complex bound to viral RNA, revealing how these viruses control their reproduction inside human cells. The study, led by Deepak Koirala and Naba Krishna Das and published in Nature Communications, focused on the 3CD protein. This fusion protein contains a 3C domain that cuts viral proteins and a 3D domain that acts as an RNA polymerase to copy the viral genome. Using X-ray crystallography, the team visualized how the 3C domain binds to a cloverleaf-shaped section of the viral RNA, recruiting host cell proteins to assemble a replication complex. The complex functions as a switch: when 3CD is attached, the virus copies its RNA; when it detaches, the RNA is used to make viral proteins.
Why this Matters to You
This discovery could lead to new treatments for a range of common and serious illnesses you or your family might encounter. Enteroviruses are responsible for polio, encephalitis, myocarditis, and many common colds. By revealing a shared, precise step these viruses use to reproduce, the research provides a clear target for new antiviral drugs. Drugs designed to interfere with the 3C and 3D proteins are already being developed, and this new structural map could make those drugs more effective. This means future outbreaks of enterovirus-related illnesses might be met with more potent and specific treatments.
What's Next
The research team demonstrated that the replication mechanism appears nearly identical across all seven enteroviruses they studied, which suggests a single drug might be effective against multiple viruses. Further research will likely test potential drug candidates against the newly visualized 3CD-RNA structure to block viral replication. The broader understanding of this fundamental viral switch may also inform the development of treatments for other RNA viruses that use similar strategies.